ATE373005T1 - Thienopyrrole als antivirale mittel - Google Patents
Thienopyrrole als antivirale mittelInfo
- Publication number
- ATE373005T1 ATE373005T1 AT04768385T AT04768385T ATE373005T1 AT E373005 T1 ATE373005 T1 AT E373005T1 AT 04768385 T AT04768385 T AT 04768385T AT 04768385 T AT04768385 T AT 04768385T AT E373005 T1 ATE373005 T1 AT E373005T1
- Authority
- AT
- Austria
- Prior art keywords
- thienopyrroles
- antiviral agents
- hepatitis
- infections
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0321003.6A GB0321003D0 (en) | 2003-09-09 | 2003-09-09 | Compounds, compositions and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE373005T1 true ATE373005T1 (de) | 2007-09-15 |
Family
ID=29226699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04768385T ATE373005T1 (de) | 2003-09-09 | 2004-09-07 | Thienopyrrole als antivirale mittel |
Country Status (11)
Country | Link |
---|---|
US (1) | US7781431B2 (de) |
EP (1) | EP1664059B1 (de) |
JP (1) | JP2007505091A (de) |
CN (1) | CN1849323A (de) |
AT (1) | ATE373005T1 (de) |
AU (1) | AU2004270470A1 (de) |
CA (1) | CA2537545A1 (de) |
DE (1) | DE602004008945T2 (de) |
ES (1) | ES2291933T3 (de) |
GB (1) | GB0321003D0 (de) |
WO (1) | WO2005023819A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200600424B (en) | 2003-08-01 | 2007-05-30 | Genelabs Tech Inc | Bicyclic imidazol derivatives against flaviviridae |
EP1688420A4 (de) * | 2003-11-19 | 2008-10-22 | Japan Tobacco Inc | 5-5-gliedrige kondensierte heterocyclische verbindung und deren verwendung als hcv-polymeraseinhibitor |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
GB0416396D0 (en) * | 2004-07-22 | 2004-08-25 | Angeletti P Ist Richerche Bio | Therapeutic agents |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
AU2006242475B2 (en) | 2005-05-02 | 2011-07-07 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
GB0509326D0 (en) * | 2005-05-09 | 2005-06-15 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
CA2615896C (en) | 2005-08-01 | 2012-11-13 | Merck & Co., Inc. | Macrocyclic peptides as hcv ns3 protease inhibitors |
GB0609492D0 (en) | 2006-05-15 | 2006-06-21 | Angeletti P Ist Richerche Bio | Therapeutic agents |
GB0612423D0 (en) | 2006-06-23 | 2006-08-02 | Angeletti P Ist Richerche Bio | Therapeutic agents |
CA2667165A1 (en) | 2006-10-24 | 2008-05-02 | Merck & Co., Inc. | Hcv ns3 protease inhibitors |
EP2079479B1 (de) | 2006-10-24 | 2014-11-26 | Merck Sharp & Dohme Corp. | Inhibitoren der hcv-ns3-protease |
US8309540B2 (en) | 2006-10-24 | 2012-11-13 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
KR101615500B1 (ko) | 2006-10-27 | 2016-04-27 | 머크 샤프 앤드 돔 코포레이션 | Hcv ns3 프로테아제 억제제 |
CN101568346B (zh) | 2006-10-27 | 2015-11-25 | 默沙东公司 | Hcv ns3蛋白酶抑制剂 |
GB0625345D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
US8101595B2 (en) | 2006-12-20 | 2012-01-24 | Istituto di Ricerche di Biologia Molecolare P. Angletti SpA | Antiviral indoles |
GB0625349D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
WO2009010785A1 (en) | 2007-07-17 | 2009-01-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Macrocyclic indole derivatives for the treatment of hepatitis c infections |
US8927569B2 (en) | 2007-07-19 | 2015-01-06 | Merck Sharp & Dohme Corp. | Macrocyclic compounds as antiviral agents |
EA201000948A1 (ru) | 2007-12-19 | 2011-02-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Ингибиторы вирусной полимеразы |
US8461107B2 (en) | 2008-04-28 | 2013-06-11 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
US8126839B2 (en) * | 2008-06-19 | 2012-02-28 | Yahoo! Inc. | Methods and apparatuses for adapting a ranking function of a search engine for use with a specific domain |
ME02024B (me) | 2008-07-22 | 2015-05-20 | Merck Sharp & Dohme | Makrociklična jedinjenja hinoksalina kao inhibitori hcv ns3 proteaze |
JP2012514605A (ja) | 2009-01-07 | 2012-06-28 | サイネクシス,インコーポレーテッド | Hcvおよびhiv感染の治療への使用におけるシクロスポリン誘導体 |
US8828930B2 (en) | 2009-07-30 | 2014-09-09 | Merck Sharp & Dohme Corp. | Hepatitis C virus NS3 protease inhibitors |
US20110152243A1 (en) * | 2009-12-23 | 2011-06-23 | Abbott Laboratories | Novel thienopyrrole compounds |
CN105399697A (zh) * | 2014-09-12 | 2016-03-16 | 苏州旺山旺水生物医药有限公司 | 一种氨基磺酰基类化合物、其制备方法及用途 |
EP3246330A1 (de) * | 2016-05-18 | 2017-11-22 | Istituto Europeo di Oncologia S.r.l. | Imidazoles als histone demethylase inhibitoren |
WO2020040104A1 (ja) | 2018-08-21 | 2020-02-27 | 杏林製薬株式会社 | 2環性ヘテロ芳香環誘導体 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3706810A (en) * | 1970-09-15 | 1972-12-19 | American Cyanamid Co | N-morpholinoalkyl-thieno(3,2-b)pyrrole-5-carboxamides |
SU367098A1 (ru) * | 1971-01-20 | 1973-01-23 | Способ получения производных 4,5-диоксотиено- - | |
SU478833A1 (ru) * | 1972-12-29 | 1975-07-30 | Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе | Способ получени производных тиено -(3,2-в)-пиррола |
JPH04356029A (ja) | 1990-07-02 | 1992-12-09 | Japan Synthetic Rubber Co Ltd | 非線形光学素子 |
JPH04179949A (ja) * | 1990-11-15 | 1992-06-26 | Fuji Photo Film Co Ltd | 新規な色素形成カプラーおよび該カプラーを用いたハロゲン化銀カラー写真感光材料 |
US5340833A (en) * | 1992-05-01 | 1994-08-23 | Eisai Co., Ltd. | Urokinase inhibitors |
CZ20013424A3 (cs) | 1999-12-27 | 2002-02-13 | Japan Tobacco Inc. | Sloučeniny s fúzovanými kruhy a jejich pouľití jako léčiva |
US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
JP2003212846A (ja) * | 2001-06-26 | 2003-07-30 | Japan Tobacco Inc | 縮合環化合物及びc型肝炎治療剤 |
AR035543A1 (es) | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
JP4558314B2 (ja) | 2001-07-20 | 2010-10-06 | ベーリンガー インゲルハイム (カナダ) リミテッド | ウイルスポリメラーゼインヒビター |
EP2335700A1 (de) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C Virus Polymerase Inhibitoren mit heterobicylischer Struktur |
EP1429759A4 (de) | 2001-09-26 | 2004-12-15 | Bristol Myers Squibb Co | Verbindungen zur behandlung des hepatitus c virus |
GB0222909D0 (en) * | 2002-10-03 | 2002-11-13 | Astrazeneca Ab | Novel process and intermediates |
EP1620427A1 (de) * | 2003-04-17 | 2006-02-01 | Pfizer Products Inc. | Carbonsäureamid-derivate als antidiabetika |
-
2003
- 2003-09-09 GB GBGB0321003.6A patent/GB0321003D0/en not_active Ceased
-
2004
- 2004-09-07 EP EP04768385A patent/EP1664059B1/de active Active
- 2004-09-07 JP JP2006525884A patent/JP2007505091A/ja active Pending
- 2004-09-07 AT AT04768385T patent/ATE373005T1/de not_active IP Right Cessation
- 2004-09-07 ES ES04768385T patent/ES2291933T3/es active Active
- 2004-09-07 WO PCT/GB2004/003838 patent/WO2005023819A1/en active Application Filing
- 2004-09-07 CA CA002537545A patent/CA2537545A1/en not_active Abandoned
- 2004-09-07 US US10/571,234 patent/US7781431B2/en not_active Expired - Fee Related
- 2004-09-07 DE DE602004008945T patent/DE602004008945T2/de active Active
- 2004-09-07 CN CNA2004800257994A patent/CN1849323A/zh active Pending
- 2004-09-07 AU AU2004270470A patent/AU2004270470A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2005023819A1 (en) | 2005-03-17 |
CN1849323A (zh) | 2006-10-18 |
WO2005023819A9 (en) | 2006-03-23 |
JP2007505091A (ja) | 2007-03-08 |
EP1664059A1 (de) | 2006-06-07 |
US7781431B2 (en) | 2010-08-24 |
CA2537545A1 (en) | 2005-03-17 |
DE602004008945T2 (de) | 2008-05-29 |
ES2291933T3 (es) | 2008-03-01 |
AU2004270470A1 (en) | 2005-03-17 |
GB0321003D0 (en) | 2003-10-08 |
EP1664059B1 (de) | 2007-09-12 |
US20090036443A1 (en) | 2009-02-05 |
DE602004008945D1 (en) | 2007-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE373005T1 (de) | Thienopyrrole als antivirale mittel | |
DE602005023015D1 (de) | Indolderivate als viruzide | |
WO2006027628A3 (en) | Naphthalimide derivatives as antiviral agents | |
NZ609146A (en) | Modified 4’-nucleosides as antiviral agents | |
MX2007004979A (es) | Derivados de indol tetraciclicos como agentes antiviricos. | |
ATE504579T1 (de) | Antivirale mittel | |
HK1108703A1 (en) | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection | |
ECSP044992A (es) | Inhibidores de la alquín-aril fosfodiesterasa-4 | |
CY1110835T1 (el) | Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c | |
GEP20063938B (en) | Hepatitis c virus inhibitors | |
EA200401436A1 (ru) | Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция | |
ECSP056181A (es) | Compuestos Inhibidores de la Hepatitis C | |
WO2007029029A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
ATE438637T1 (de) | Thiophenderivate als antivirale mittel gegen flavivirus-infektion | |
NO20060973L (no) | Pyridylderivater og deres anvendelse som tempeutiske midler | |
DE60236102D1 (en) | 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren | |
ATE526341T1 (de) | Makrozyklische verbindungen als antivirale mittel | |
CY1110690T1 (el) | Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv | |
DE60316338D1 (de) | N-alkyl-4-methylenamino-3-hydroxy-2-pyridone verwendbar als antimikrobielle mittel | |
MXPA06000418A (es) | Derivados de ariltiourea sustituida utiles como inhibidores de duplicacion viral. | |
DE60221508D1 (de) | Aminosäurederivate als hiv-protease-inhibitoren | |
ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
WO2004037784A3 (en) | Pyrrolidones with anti-hiv activity | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
DE602005010607D1 (de) | Zyklosporinanalog |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |